THRD Projected Dividend Yield
Third Harmonic Bio Inc ( NASDAQ : THRD )Third Harmonic Bio, Inc. is a biopharmaceutical company. Co. is focused on advancing the next wave of medicine for inflammatory diseases through the development of novel, small-molecule inhibitors of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. It is developing medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. Mast cells are a part of the immune system, and dysfunctional mast cell activity has been implicated in the pathophysiology of a broad range of inflammatory disorders including urticaria, asthma and gastrointestinal disorders, among others. 21 YEAR PERFORMANCE RESULTS |
THRD Dividend History Detail THRD Dividend News THRD Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |